Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 159 | 224 | 142 | 24,328 | 1,528 |
| Cost of Goods | 64 | 85 | 54 | 1,606 | 3,712 |
| Gross Profit | 95 | 139 | 88 | 22,722 | -2,184 |
| Operating Expenses | 26,339 | 22,778 | 28,497 | 25,800 | 27,975 |
| Operating Income | -26,244 | -22,639 | -28,409 | -3,078 | -30,159 |
| Interest Expense | N/A | N/A | N/A | N/A | 11,511 |
| Other Income | 5,287 | -4,705 | -121 | 26,815 | 1,313 |
| Pre-tax Income | -20,957 | -27,344 | -28,530 | 23,736 | -40,358 |
| Income Tax | 1 | 10 | 0 | 9,562 | -4,210 |
| Net Income Continuous | -20,958 | -27,354 | -28,530 | 14,174 | -36,148 |
| Net Income | $-20,958 | $-27,354 | $-28,530 | $14,174 | $-36,148 |
| EBITDA(a) | $-26,088 | $-22,491 | $-28,271 | $-6,544 | $-28,675 |